How sustainability shapes the future of biopharma

Explore how sustainability drives wellbeing in life sciences. Discover insights. Listen now.

In this episode of the EY Nordic Fit for Future Podcast, host Jessica Schmidt explores how sustainability is reshaping the biopharmaceutical industry with guests Joseffa Moritz and Daniel Brämhagen.

What happens when science meets sustainability?

In this episode of the EY Nordic Fit for Future Podcast, we explore how the biopharmaceutical sector is rethinking its role in shaping a healthier, more sustainable world. Host Jessica Schmidt welcomes Joseffa Moritz, Head of Corporate Affairs Nordics at Bristol Myers Squibb, and Daniel Brämhagen, EY Nordic People Sustainability Lead, for a deep dive into the industry’s shift toward greener, more human-centered care.

Listen in as they unpack the evolving responsibilities of life sciences — from reducing environmental impact to improving health equity and employee wellbeing.

This conversation also offers practical examples, surprising insights and bold ideas about personalized care, cross-sector collaboration and the growing momentum toward value-based health systems.

Key takeaways:
  • Understand why sustainability is essential to the biopharmaceutical sector.
  • Learn how companies integrate health equity and wellbeing into strategy.
  • Discover innovative partnerships and social sustainability projects.
  • Explore future trends in personalized, preventive and value-based care.

Presenters

Jessica Schmidt

Jessica Schmidt
Client Executive and Nordic Future of Work Strategy Lead, Associate Director, EY Markets & Business Development

Podcast

Season 2 Episode 7

Duration

29m 30s